Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Total RadIoTherapy of Oligometastatic caNcerS (TRITONS)

NCT06587490 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06587490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06587490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Total RadIoTherapy of Oligometastatic caNcerS (TRITONS)
Lead sponsor
University of California, San Diego
Phase
Phase 3
Overall status
Recruiting
Start date
November 12, 2024
Completion date
November 30, 2034
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic malignant solid neoplasm